Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



New hematological biomarkers in patients with atrial septal aneurysm

Saadet Demirtas Inci, Sabiye Yilmaz.




Abstract

Mean platelet volume/platelet count (MPV/PC) and monocyte/lymphocyte (MLR), neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) ratios are new hematological markers showing systemic platelet activation and inflammation. The aim of this study was to compare new hematological markers in patients with atrial septal aneurysm (ASA) and to determine their relationship in patients with ASA. 70 ASA and 47 healthy subjects (as control group) were included in the study. Demographic, clinical, echocardiographic and hematological values of the groups were recorded. MPV/PC ratio and MLR were significantly higher in ASA group compared to control group (0.03 ± 0.013 vs 0.02 ± 0.009, P=0.02 and 0.27 ± 0.15 vs 0.22 ± 0.08, P=0.03). NLR and PLR were not different between the groups. The presence of ASA was positively correlated with MLR and MPV/PC, left atrium, left ventricular (LV) septum thickness and LV posterior wall thickness, while red blood cell (RBC) was negatively correlated. However, in multivariate linear regression analysis, there was an independent relation between the presence of ASA and MPV/PC, MLR, LV septum thickness and RBC. We found that MPV/PC ratio and MLR from new hematological biomarkers are independent predictors for the presence of ASA.

Key words: Atrial septal aneurysm, inflammation, platelet






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.